| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 16.982 | 243.466 | 242.047 | 223.276 | 254.991 | - | - | - | - |
| Total Income - EUR | - | 16.982 | 243.665 | 242.197 | 223.276 | 256.294 | - | - | - | - |
| Total Expenses - EUR | - | 12.392 | 187.229 | 199.270 | 187.787 | 219.166 | - | - | - | - |
| Gross Profit/Loss - EUR | - | 4.590 | 56.436 | 42.927 | 35.490 | 37.128 | - | - | - | - |
| Net Profit/Loss - EUR | - | 4.081 | 54.001 | 40.507 | 33.255 | 34.892 | - | - | - | - |
| Employees | - | 0 | 1 | 3 | 3 | 4 | - | - | - | - |
Check the financial reports for the company - Propharma Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 94 | 3.325 | 6.223 | 3.937 | 6.386 | - | - | - | - |
| Current Assets | - | 19.197 | 79.073 | 128.781 | 174.513 | 170.651 | - | - | - | - |
| Inventories | - | 13.808 | 20.694 | 17.838 | 16.445 | 5.603 | - | - | - | - |
| Receivables | - | 0 | 44.361 | 90.743 | 141.603 | 147.797 | - | - | - | - |
| Cash | - | 5.389 | 14.019 | 20.200 | 16.465 | 17.251 | - | - | - | - |
| Shareholders Funds | - | 4.125 | 54.050 | 93.565 | 119.742 | 113.398 | - | - | - | - |
| Social Capital | - | 45 | 44 | 43 | 44 | 43 | - | - | - | - |
| Debts | - | 15.166 | 28.349 | 41.440 | 58.730 | 63.639 | - | - | - | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Propharma Plus S.r.l.